the central pharmacy limited Company Information
Company Number
SC185507
Registered Address
suite 2, ground floor, orchard brae house, edinburgh, EH4 2HS
Industry
Other business support service activities n.e.c.
Telephone
01259722851
Next Accounts Due
December 2024
Group Structure
View All
Directors
Rose Gray26 Years
Shareholders
communicare medical limited 100%
the central pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of THE CENTRAL PHARMACY LIMITED at £1.5m based on a Turnover of £2.5m and 0.59x industry multiple (adjusted for size and gross margin).
the central pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of THE CENTRAL PHARMACY LIMITED at £481.9k based on an EBITDA of £105.3k and a 4.58x industry multiple (adjusted for size and gross margin).
the central pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of THE CENTRAL PHARMACY LIMITED at £1.3m based on Net Assets of £512.9k and 2.54x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
The Central Pharmacy Limited Overview
The Central Pharmacy Limited is a live company located in edinburgh, EH4 2HS with a Companies House number of SC185507. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in April 1998, it's largest shareholder is communicare medical limited with a 100% stake. The Central Pharmacy Limited is a mature, small sized company, Pomanda has estimated its turnover at £2.5m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
The Central Pharmacy Limited Health Check
Pomanda's financial health check has awarded The Central Pharmacy Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 3 areas for improvement. Company Health Check FAQs
1 Strong
8 Regular
3 Weak
Size
annual sales of £2.5m, make it in line with the average company (£3m)
- The Central Pharmacy Limited
£3m - Industry AVG
Growth
3 year (CAGR) sales growth of -2%, show it is growing at a slower rate (4.1%)
- The Central Pharmacy Limited
4.1% - Industry AVG
Production
with a gross margin of 38.5%, this company has a comparable cost of product (38.5%)
- The Central Pharmacy Limited
38.5% - Industry AVG
Profitability
an operating margin of 1% make it less profitable than the average company (6.5%)
- The Central Pharmacy Limited
6.5% - Industry AVG
Employees
with 21 employees, this is similar to the industry average (20)
21 - The Central Pharmacy Limited
20 - Industry AVG
Pay Structure
on an average salary of £43.5k, the company has an equivalent pay structure (£43.5k)
- The Central Pharmacy Limited
£43.5k - Industry AVG
Efficiency
resulting in sales per employee of £118.9k, this is equally as efficient (£137.2k)
- The Central Pharmacy Limited
£137.2k - Industry AVG
Debtor Days
it gets paid by customers after 41 days, this is near the average (40 days)
- The Central Pharmacy Limited
40 days - Industry AVG
Creditor Days
its suppliers are paid after 80 days, this is slower than average (34 days)
- The Central Pharmacy Limited
34 days - Industry AVG
Stock Days
it holds stock equivalent to 47 days, this is more than average (29 days)
- The Central Pharmacy Limited
29 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 23 weeks, this is average cash available to meet short term requirements (28 weeks)
23 weeks - The Central Pharmacy Limited
28 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 62%, this is a similar level of debt than the average (60.4%)
62% - The Central Pharmacy Limited
60.4% - Industry AVG
THE CENTRAL PHARMACY LIMITED financials
The Central Pharmacy Limited's latest turnover from March 2023 is estimated at £2.5 million and the company has net assets of £512.9 thousand. According to their latest financial statements, The Central Pharmacy Limited has 21 employees and maintains cash reserves of £228.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | ||||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | ||||||||||||||
Pre-Tax Profit | ||||||||||||||
Tax | ||||||||||||||
Profit After Tax | ||||||||||||||
Dividends Paid | ||||||||||||||
Retained Profit | ||||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | 21 | 23 | 25 | 23 | 24 | 23 | 22 | 22 | ||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 196,675 | 232,514 | 199,761 | 99,072 | 113,625 | 126,373 | 140,093 | 147,020 | 335,155 | 362,329 | 545,902 | 600,795 | 660,045 | 640,391 |
Intangible Assets | 275,197 | 317,536 | 359,874 | 402,212 | 444,549 | 486,887 | 529,225 | 571,563 | 613,901 | 656,239 | 1,300,227 | 1,384,055 | 1,467,888 | 1,551,716 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 471,872 | 550,050 | 559,635 | 501,284 | 558,174 | 613,260 | 669,318 | 718,583 | 949,056 | 1,018,568 | 1,846,129 | 1,984,850 | 2,127,933 | 2,192,107 |
Stock & work in progress | 200,764 | 178,013 | 198,139 | 228,139 | 175,228 | 171,187 | 158,704 | 153,121 | 136,165 | 127,421 | 154,901 | 147,753 | 174,701 | 163,789 |
Trade Debtors | 283,902 | 235,799 | 230,788 | 274,190 | 226,616 | 266,831 | 216,504 | 305,578 | 349,086 | 321,244 | 384,438 | 453,950 | 470,379 | 469,658 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 165,967 | 164,452 | 157,124 | 162,618 | 140,139 | 142,278 | 110,555 | 36,870 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 228,234 | 287,894 | 365,153 | 280,770 | 177,913 | 141,975 | 180,577 | 200,012 | 120,654 | 76,617 | 98,323 | 162,321 | 190,857 | 227,763 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 878,867 | 866,158 | 951,204 | 945,717 | 719,896 | 722,271 | 666,340 | 695,581 | 605,905 | 525,282 | 637,662 | 764,024 | 835,937 | 861,210 |
total assets | 1,350,739 | 1,416,208 | 1,510,839 | 1,447,001 | 1,278,070 | 1,335,531 | 1,335,658 | 1,414,164 | 1,554,961 | 1,543,850 | 2,483,791 | 2,748,874 | 2,963,870 | 3,053,317 |
Bank overdraft | 75,051 | 58,361 | 41,530 | 34,851 | 33,662 | 33,662 | 33,666 | 32,510 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 338,608 | 337,905 | 314,761 | 425,022 | 361,604 | 340,803 | 315,887 | 400,510 | 725,064 | 628,097 | 962,145 | 1,011,188 | 1,038,126 | 863,065 |
Group/Directors Accounts | 19,493 | 19,493 | 54,493 | 20,063 | 20,628 | 20,628 | 20,628 | 32,128 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 71,587 | 65,291 | 102,739 | 86,852 | 67,919 | 77,288 | 74,973 | 66,076 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 504,739 | 481,050 | 513,523 | 566,788 | 483,813 | 472,381 | 445,154 | 531,224 | 725,064 | 628,097 | 962,145 | 1,011,188 | 1,038,126 | 863,065 |
loans | 327,304 | 405,038 | 465,216 | 394,579 | 424,066 | 458,321 | 493,926 | 527,588 | 422,968 | 406,301 | 365,492 | 555,764 | 740,551 | 924,185 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137,126 | 292,776 | 743,532 | 737,680 | 746,235 | 756,625 |
provisions | 5,757 | 9,558 | 4,867 | 1,386 | 3,509 | 5,246 | 4,725 | 5,073 | 0 | 0 | 15,137 | 18,301 | 13,843 | 19,146 |
total long term liabilities | 333,061 | 414,596 | 470,083 | 395,965 | 427,575 | 463,567 | 498,651 | 532,661 | 560,094 | 699,077 | 1,124,161 | 1,311,745 | 1,500,629 | 1,699,956 |
total liabilities | 837,800 | 895,646 | 983,606 | 962,753 | 911,388 | 935,948 | 943,805 | 1,063,885 | 1,285,158 | 1,327,174 | 2,086,306 | 2,322,933 | 2,538,755 | 2,563,021 |
net assets | 512,939 | 520,562 | 527,233 | 484,248 | 366,682 | 399,583 | 391,853 | 350,279 | 269,803 | 216,676 | 397,485 | 425,941 | 425,115 | 490,296 |
total shareholders funds | 512,939 | 520,562 | 527,233 | 484,248 | 366,682 | 399,583 | 391,853 | 350,279 | 269,803 | 216,676 | 397,485 | 425,941 | 425,115 | 490,296 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | ||||||||||||||
Depreciation | 37,182 | 36,866 | 14,144 | 19,243 | 18,657 | 18,352 | 16,802 | 16,376 | 28,132 | 43,692 | 55,912 | 62,693 | 67,700 | 57,424 |
Amortisation | 42,339 | 42,338 | 42,338 | 42,337 | 42,338 | 42,338 | 42,338 | 42,338 | 42,338 | 63,082 | 83,828 | 83,833 | 83,828 | 62,660 |
Tax | ||||||||||||||
Stock | 22,751 | -20,126 | -30,000 | 52,911 | 4,041 | 12,483 | 5,583 | 16,956 | 8,744 | -27,480 | 7,148 | -26,948 | 10,912 | 163,789 |
Debtors | 49,618 | 12,339 | -48,896 | 70,053 | -42,354 | 82,050 | -15,389 | -6,638 | 27,842 | -63,194 | -69,512 | -16,429 | 721 | 469,658 |
Creditors | 703 | 23,144 | -110,261 | 63,418 | 20,801 | 24,916 | -84,623 | -324,554 | 96,967 | -334,048 | -49,043 | -26,938 | 175,061 | 863,065 |
Accruals and Deferred Income | 6,296 | -37,448 | 15,887 | 18,933 | -9,369 | 2,315 | 8,897 | 66,076 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | -3,801 | 4,691 | 3,481 | -2,123 | -1,737 | 521 | -348 | 5,073 | 0 | -15,137 | -3,164 | 4,458 | -5,303 | 19,146 |
Cash flow from operations | ||||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | -35,000 | 34,430 | -565 | 0 | 0 | -11,500 | 32,128 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | -77,734 | -60,178 | 70,637 | -29,487 | -34,255 | -35,605 | -33,662 | 104,620 | 16,667 | 40,809 | -190,272 | -184,787 | -183,634 | 924,185 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -137,126 | -155,650 | -450,756 | 5,852 | -8,555 | -10,390 | 756,625 |
share issue | ||||||||||||||
interest | ||||||||||||||
cash flow from financing | ||||||||||||||
cash and cash equivalents | ||||||||||||||
cash | -59,660 | -77,259 | 84,383 | 102,857 | 35,938 | -38,602 | -19,435 | 79,358 | 44,037 | -21,706 | -63,998 | -28,536 | -36,906 | 227,763 |
overdraft | 16,690 | 16,831 | 6,679 | 1,189 | 0 | -4 | 1,156 | 32,510 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -76,350 | -94,090 | 77,704 | 101,668 | 35,938 | -38,598 | -20,591 | 46,848 | 44,037 | -21,706 | -63,998 | -28,536 | -36,906 | 227,763 |
the central pharmacy limited Credit Report and Business Information
The Central Pharmacy Limited Competitor Analysis
Perform a competitor analysis for the central pharmacy limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other small companies, companies in EH4 area or any other competitors across 12 key performance metrics.
the central pharmacy limited Ownership
THE CENTRAL PHARMACY LIMITED group structure
The Central Pharmacy Limited has no subsidiary companies.
Ultimate parent company
1 parent
THE CENTRAL PHARMACY LIMITED
SC185507
the central pharmacy limited directors
The Central Pharmacy Limited currently has 1 director, Ms Rose Gray serving since Apr 1998.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Ms Rose Gray | Scotland | 67 years | Apr 1998 | - | Director |
P&L
March 2023turnover
2.5m
+11%
operating profit
25.8k
0%
gross margin
38.5%
+0.85%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
512.9k
-0.01%
total assets
1.4m
-0.05%
cash
228.2k
-0.21%
net assets
Total assets minus all liabilities
the central pharmacy limited company details
company number
SC185507
Type
Private limited with Share Capital
industry
82990 - Other business support service activities n.e.c.
incorporation date
April 1998
age
26
incorporated
UK
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
last accounts submitted
March 2023
address
suite 2, ground floor, orchard brae house, edinburgh, EH4 2HS
accountant
WHITELAW WELLS
auditor
-
the central pharmacy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 5 charges/mortgages relating to the central pharmacy limited. Currently there are 1 open charges and 4 have been satisfied in the past.
the central pharmacy limited Companies House Filings - See Documents
date | description | view/download |
---|